Paper42869578PubMed
Sensory innervation shapes cancer immunotherapy efficacy and adverse events.
Adamczyk NS and 2 others. J Immunother Cancer, 2026.
Cite this record
ConductScience Library. Sensory innervation shapes cancer immunotherapy efficacy and adverse events. Papers, record 42869578. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42869578
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sensory innervation shapes cancer immunotherapy efficacy and adverse events.
- Journal
- J Immunother Cancer
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-17
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA285585 | NCI NIH HHS | United States | R01CA285585 | PubMed | NIH RePORTER |
| R01 DE033473 | NIDCR NIH HHS | United States | R01DE033473 | PubMed | NIH RePORTER |
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33334813 | Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk. | Cancer Res | 2021 | https://conductscience.org/library/papers/33334813 | PubMed |
| 2 | 38749213 | Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer. | Biomater Adv | 2024 | https://conductscience.org/library/papers/38749213 | PubMed |
| 3 | 17631638 | Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. | Int J Cancer | 2007 | https://conductscience.org/library/papers/17631638 | PubMed |
| 4 | 30109819 | Neuroimmune Communication in Health and Disease. | Physiol Rev | 2018 | https://conductscience.org/library/papers/30109819 | PubMed |
| 5 | 37059069 | Cancer neuroscience: State of the field, emerging directions. | Cell | 2023 | https://conductscience.org/library/papers/37059069 | PubMed |
| 6 | 40320550 | Cancer-nervous system crosstalk: from biological mechanism to therapeutic opportunities. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40320550 | PubMed |
| 7 | 28386018 | PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk. | Cancer Res | 2017 | https://conductscience.org/library/papers/28386018 | PubMed |
| 8 | 38653601 | Sensory neuronal control of skin barrier immunity. | Trends Immunol | 2024 | https://conductscience.org/library/papers/38653601 | PubMed |
| 9 | 31163177 | Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice. | Gastroenterology | 2019 | https://conductscience.org/library/papers/31163177 | PubMed |
| 10 | 21907491 | Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. | Pain | 2011 | https://conductscience.org/library/papers/21907491 | PubMed |
| 11 | 36089217 | Neuronally expressed PDL1, not PD1, suppresses acute nociception. | Brain Behav Immun | 2022 | https://conductscience.org/library/papers/36089217 | PubMed |
| 12 | 37286351 | Metastatic Infiltration of Nervous Tissue and Periosteal Nerve Sprouting in Multiple Myeloma-Induced Bone Pain in Mice and Human. | J Neurosci | 2023 | https://conductscience.org/library/papers/37286351 | PubMed |
| 13 | 23345604 | Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells. | Mol Cancer Res | 2013 | https://conductscience.org/library/papers/23345604 | PubMed |
| 14 | 33142805 | Delicate Role of PD-L1/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33142805 | PubMed |
| 15 | 18176559 | NGF-promoted axon growth and target innervation requires GITRL-GITR signaling. | Nat Neurosci | 2008 | https://conductscience.org/library/papers/18176559 | PubMed |
| 16 | 41650969 | Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment. | Cell | 2026 | https://conductscience.org/library/papers/41650969 | PubMed |
| 17 | 42525785 | Neural architecture as cancer's safe harbor. | Sci Transl Med | 2026 | https://conductscience.org/library/papers/42525785 | PubMed |
| 18 | 15721238 | Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 Semaphorins. | Neuron | 2005 | https://conductscience.org/library/papers/15721238 | PubMed |
| 19 | 27708076 | Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3. | Science | 2016 | https://conductscience.org/library/papers/27708076 | PubMed |
| 20 | 33442058 | STING controls nociception via type I interferon signalling in sensory neurons. | Nature | 2021 | https://conductscience.org/library/papers/33442058 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42869578
GET https://conductscience.org/api/papers/v1/42869578/references?page=2